diclofenac has been researched along with Overweight in 1 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
Overweight: A status with BODY WEIGHT that is above certain standards. In the scale of BODY MASS INDEX, overweight is defined as having a BMI of 25.0-29.9 kg/m2. Overweight may or may not be due to increases in body fat (ADIPOSE TISSUE), hence overweight does not equal over fat.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To address this limitation, we used an integrative omics approach to characterize modulation of inflammation in overweight men during an intervention with the non-steroidal anti-inflammatory drug diclofenac." | 9.14 | Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. ( Cnubben, NH; Hendriks, HF; Newman, JW; Pedersen, TL; Rubingh, C; Smilde, AK; van der Greef, J; van Erk, MJ; van Ommen, B; van Vliet, T; Verheij, E; Wopereis, S, 2010) |
| "To address this limitation, we used an integrative omics approach to characterize modulation of inflammation in overweight men during an intervention with the non-steroidal anti-inflammatory drug diclofenac." | 5.14 | Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study. ( Cnubben, NH; Hendriks, HF; Newman, JW; Pedersen, TL; Rubingh, C; Smilde, AK; van der Greef, J; van Erk, MJ; van Ommen, B; van Vliet, T; Verheij, E; Wopereis, S, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van Erk, MJ | 1 |
| Wopereis, S | 1 |
| Rubingh, C | 1 |
| van Vliet, T | 1 |
| Verheij, E | 1 |
| Cnubben, NH | 1 |
| Pedersen, TL | 1 |
| Newman, JW | 1 |
| Smilde, AK | 1 |
| van der Greef, J | 1 |
| Hendriks, HF | 1 |
| van Ommen, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Relation Between Reduction of the Inflammatory Status and Glucose Metabolism in Healthy Overweight Men[NCT00221052] | 20 participants | Interventional | 2005-06-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for diclofenac and Overweight
| Article | Year |
|---|---|
Insight in modulation of inflammation in response to diclofenac intervention: a human intervention study.
Topics: Adult; Annexin A1; Anti-Inflammatory Agents, Non-Steroidal; Body Mass Index; Caspase 8; Diclofenac; | 2010 |